Basel Medical Group Ltd - ordinary shares (BMGL)
0.5710
+0.0010 (0.18%)
NASDAQ · Last Trade: Apr 20th, 8:42 AM EDT
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Basel Medical Group Ltd. (NASDAQ: BMGL) resulting from allegations that Basel Medical may have issued materially misleading business information to the investing public.
By The Rosen Law Firm, P.A. · Via Business Wire · April 14, 2026

The CHIPS and Science Act, a landmark $280 billion initiative, is designed to bolster domestic semiconductor manufacturing, strengthen supply chain resilience, and advance technologies critical to national security. Peraso Inc. (NASDAQ: PRSO), whose fixed wireless access (FWA) solutions rely on cutting-edge semiconductors, stands to benefit significantly from this federal initiative.
Via AB Newswire · May 30, 2025